Tuberculosis (TB)

Transforming the HIV/TB Response: Defining the next 10 years

21 July, 2012 | Washington DC, USA
The World Health Organization, in collaboration with Georgetown University, organized a high level international consultation on behalf of the TB/HIV Working Group of the Stop TB Partnership, in conjunction with the AIDS 2012 conference in Washington DC on July 21, 2012. The aim of the meeting was to discuss innovative ideas and ways to define and shape the global TB/HIV response for the next decade. It also harvested experiences and identified key challenges and barriers in the scale-up of collaborative TB/HIV activities, including key research gaps.

Co-hosted by Diane Havlir of the University of San Francisco and Chair of AIDS 2012 and the TB/HIV Working Group, and Mark Dybul of Georgetown University and George W Bush Institute and former US Global AIDS Coordinator, and convened by Haileyesus Getahun of the Stop TB Department of WHO, the meeting was attended by some 130 participants, including opinion leaders, global policy makers, leading scientists, activists and national HIV and TB programme managers. The morning session opened with presentations and a high level panel discussion comprising Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, Gottfried Hirnschall, Director of WHO’s HIV/AIDS Department, Mark Harrington, Executive Director of Treatment Action Group, Debrework Zewdie, Deputy Executive Director of the Global Fund and Eric Goosby, the US Global AIDS Coordinator. Following the presentation on global and regional progress of TB/HIV collaborative activities by Diane Havlir, meeting participants also reviewed countries’ key challenges and experiences in the scaling up collaborative TB/HIV activities, presented by Director of the Bureau of Disease Control’s Division of HIV/AIDS Prevention and Management of the People’s Republic China, Xia Gang, and by the National Programme Officer of the National AIDS Control Organisation of India, BB Rewari. New evidence, actions and prospects for the next ten years on prevention, diagnosis and treatment were presented by Richard Chaisson, Professor at Johns Hopkins University in Baltimore; Stephen Lawn, Reader in Infectious Diseases and Tropical Medicine at the London School of Hygiene and Tropical Medicine and Associate Professor at the University of Cape Town; and Moses Kamya, Associate Professor at Makerere University, Uganda. In addition, neglected areas such as childhood TB, HIV related TB in prisons and the convergence of drug use and hepatitis in drug users were presented by Soumya Swaminathan, Assistant Director of India’s Tuberculosis Research Centre; Stewart Reid, CIDZ’s Medical Director and Associate Professor with the University of Alabama at Birmingham; and Chris Beyrer, Associate Director of Public Health at Johns Hopkins Center for Global Health, respectively.

For the meeting agenda and presentations please visit the links below.

Share